Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-31

Clinical Trial Update: Relieving Vasomotor Symptoms Effectively With Bioidentical Hormone Replacement Therapy: The REVERT Study

View source ↗

Summary

The REVERT study evaluated relief of vasomotor symptoms with bioidentical hormone replacement therapy in menopause; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bioidentical Hormone Replacement Therapy

Snippet

Sponsor: Medimix Specialty Pharmacy, LLC | Conditions: Menopause | Status: COMPLETED